FDA Releases New Chapter of PC Human Food Draft Guidance on Developing A Recall Plan

Nov 04, 2019 | Michelle Shapiro

The U.S. Food and Drug Administration (FDA) is announcing the availability of draft guidance that explains how food facilities subject to the Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food (CGMP & PC Human Food) rule can establish and implement a written recall plan.

This is Chapter 14 of the draft guidance, entitled “Draft Guidance for Industry: Hazard Analysis and Risk-Based Preventive Controls for Human Food ‚” designed to help food facilities comply with the PC Human Food rule, mandated by the FDA Food Safety Modernization Act. The rule specifies that food facilities must establish a written recall plan for food that requires a preventive control that includes plans for:

  • Notifying consignees of the food being recalled, including how to return or dispose of the affected food
  • Notifying the public about any hazards presented by the food
  • Conducting effectiveness checks to verify that the recall is carried out
  • Appropriately disposing of recalled food in a way that does not present a safety concern.

The draft guidance provides recommendations that industry may choose to use when developing their recall plans. It also includes resources that the FDA has previously made available to assist with recalls which may help with the preparation of these plans.


636530147572900000

About Michelle Shapiro

Michelle Shapiro is a communication specialist for the Environmental Health & Disability team at NACCHO.

More posts by Michelle Shapiro

Related Posts

Doctor 563428 640
  • COVID-19
  • Health in All Policies
  • Leadership
  • Workforce Development

Preparing Your Local Health Department for the Future

If the pandemic has taught us one thing, it is the importance of preparedness....

Jan 15, 2021 | Guest Author

Preparing Your Local Health Department for the Future

Covid
  • COVID-19
  • Immunization

Dosing intervals for COVID-19 mRNA Vaccine

On January 6, CDC revised Interim Clinical Considerations for Use of mRNA...

Jan 14, 2021 | Beth Hess

Dosing intervals for COVID-19 mRNA Vaccine

  • Opportunity

APHA 2021 Call for Abstracts is Open

Submit an abstract to present and share research with public health leaders and...

Jan 13, 2021 | Anu Varma

APHA 2021 Call for Abstracts is Open

CRC Sim PLER
  • Webinar
  • Emergency Response

CRC SimPLER: A Practice Workshop

To introduce CRC SimPLER, ASTHO and the National Alliance for Radiation...

Jan 11, 2021 | Beth Hess

CRC SimPLER: A Practice Workshop

Coronavirus COVID 19
  • COVID-19
  • Tools & Resources
  • Epidemiology

COVID-19 Genomic Epidemiology Toolkit

The CDC Office of Advanced Molecular Detection (AMD) recently released the...

Jan 11, 2021 | Beth Hess

COVID-19 Genomic Epidemiology Toolkit

Covid
  • COVID-19
  • Webinar

NACCHO COVID-19 Webinar: Increasing Vaccination Coverage...

NACCHO invites local health department leadership and staff to join the...

Jan 08, 2021 | Beth Hess

NACCHO COVID-19 Webinar: Increasing Vaccination Coverage...

Webinar
  • COVID-19
  • Webinar

NACCHO COVID-19 Webinar: Understanding Diverse...

NACCHO invites local health department leadership and staff to join the...

Jan 08, 2021 | Beth Hess

NACCHO COVID-19 Webinar: Understanding Diverse...

Needleexchange 0
  • HIV, STI, & Viral Hepatitis

Join NACCHO’s SSP Monitoring & Evaluation Advisory Group

The National Association of County and City Health Officials (NACCHO), in...

Jan 07, 2021 | Kat Kelley

Join NACCHO’s SSP Monitoring & Evaluation Advisory Group

Orange County
  • COVID-19
  • Immunization

Orange County, NY, administers 800 COVID-19 Vaccines in...

Orange County, NY received 800 doss of the Moderna COVID-19 vaccine the morning...

Jan 07, 2021 | Beth Hess

Orange County, NY, administers 800 COVID-19 Vaccines in...

Back to Top